Newspaper Clipping of Unaudited Standalone and Consolidated Financial Results of IFL Enterprises Limited of 3rd Quarter ended 31st December, 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
IFL Enterprises Ltd submitted to BSE the newspaper clippings containing its unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025, in line with SEBI Listing Regulations. On a standalone basis, total income from operations stood at Rs 1,354.44 lakh for Q3 FY26 and Rs 4,025.31 lakh for the nine-month period, with a net profit after tax of Rs 61.15 lakh for Q3 and Rs 175.95 lakh for 9M FY26, translating to EPS of Rs 0.61 and Rs 2.03 respectively. On a consolidated basis, the period showed a loss after tax of Rs 165.29 lakh for Q3 and Rs 864.79 lakh for 9M FY26, a sharp reversal from a profit of Rs 505.73 lakh for FY25. Notably, the financial results table in the clipping is signed by Medico Intercontinental Limited (MD Samir Shah) and references www.medicointercontinental.com, suggesting a possible mismatch or shared publication. The results were approved by the board on February 14, 2026.
This is a routine compliance filing, but investors should note the divergence between profitable standalone numbers and consolidated losses, and the apparent mixing of IFL Enterprises and Medico Intercontinental results, which may warrant clarification from the company.